FRA:M12 • DE000A0STSQ8
The current stock price of M12.DE is 16.58 EUR. In the past month the price decreased by -4.38%. In the past year, price increased by 16.76%.
ChartMill assigns a technical rating of 4 / 10 to M12.DE. When comparing the yearly performance of all stocks, M12.DE is one of the better performing stocks in the market, outperforming 76.6% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to M12.DE. M12.DE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months M12.DE reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS increased by 10.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5% | ||
| ROA | 8.73% | ||
| ROE | 15.03% | ||
| Debt/Equity | 0.05 |
8 analysts have analysed M12.DE and the average price target is 28.05 EUR. This implies a price increase of 69.18% is expected in the next year compared to the current price of 16.58.
For the next year, analysts expect an EPS growth of 9.46% and a revenue growth 6.09% for M12.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EMEIS | EMEIS SA | N/A | 2.384B | ||
| CLARI | CLARIANE SE | 14.94 | 1.416B | ||
| GDS | RAMSAY GENERALE DE SANTE SA | N/A | 1.203B | ||
| RHK | RHOEN-KLINIKUM AG | 17.27 | 870.48M | ||
| GHC | GAROFALO HEALTH CARE SPA | 16.86 | 489.335M | ||
| LNA | LNA SANTE | 8.98 | 279.531M | ||
| MED | MEDICLIN AG | 4.79 | 183.35M | ||
| LIK | LIMES SCHLOSSKLINIKEN AG | 15.31 | 141.52M | ||
| MAK | MATERNUS-KLINIKEN AG | N/A | 19.922M |
View all stocks in the Health Care Facilities Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin and currently employs 152 full-time employees. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
M1 KLINIKEN AG
Gruenauer Strasse 5
Berlin BERLIN DE
Employees: 219
Phone: 4930347474414
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin and currently employs 152 full-time employees. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
The current stock price of M12.DE is 16.58 EUR. The price decreased by -0.6% in the last trading session.
M1 KLINIKEN AG (M12.DE) has a dividend yield of 3.05%. The yearly dividend amount is currently 0.
M12.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
M12.DE stock is listed on the Frankfurt Stock Exchange exchange.
The Revenue of M1 KLINIKEN AG (M12.DE) is expected to grow by 6.09% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
M1 KLINIKEN AG (M12.DE) has a market capitalization of 325.63M EUR. This makes M12.DE a Small Cap stock.